Search Results - "Majumdar, Saptorshi"

Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes by Chakraborty, Debdulal, Sengupta, Sabyasachi, Mukherjee, Angshuman, Majumdar, Saptorshi

“…Purpose: The aim of this study was to report results of macular hole closure, visual benefit and longitudinal changes in foveal architecture over 1 year…”
Get full text

Response to comment on: Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes by Chakraborty, Debdulal, Sengupta, Sabyasachi, Mukherjee, Angshuman, Majumdar, Saptorshi

Get full text

Response to comment on: Anatomical and functional outcomes one year after vitrectomy and retinal massage for large macular holes by Chakraborty, Debdulal, Sengupta, Sabyasachi, Mukherjee, Angshuman, Majumdar, Saptorshi

Get full text

Ultra-widefield image of a toxocara granuloma with an adjacent retinal break and retinal detachment by Chakraborty, Debdulal, Boral, Subhendu, Mukherjee, Angshuman, Majumdar, Saptorshi

Get full text

Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos by Venkatesh, Pradeep, Majumdar, Saptorshi S, Kakkar, Ashish, Singh, Subodh, Gogia, Varun, Garg, Satpal

“…The authors report the results of partial-thickness sclerectomy combined with mitomycin C in a nanophthalmic eye with serous retinal detachment. Partial…”
Get more information

Managing caterpillar hair induced posterior segment complications by Arnab, Das, Majumdar, Saptorshi, Sourav, Santra

Get full text

Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD by Majumdar, Saptorshi, Mukherjee, Angshuman, Sinha, Tushar Kanti, Maitra, Ritobroto, Das, Arnab, Boral, Subhendu, Bhattacharya, Ranabir, Chakraborty, Debdulal

“…Purpose: This study investigates the efficacy of transitioning patients with neovascular age-related macular degeneration (nAMD) from aflibercept (T1) to…”
Get full text

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration by Majumdar, Saptorshi, Sinha, Tushar Kanti, Maitra, Ritobroto, Das, Arnab, Mondal, Soumen, Boral, Subhendu, Bhattacharya, Ranabir, Chakraborty, Debdulal

“…Purpose: To analyse outcomes of innovator ranibizumab (IRM) (Lucentis) and biosimilar ranibizumab (BRM) (Razumab) in Indian eyes with neovascular age-related…”
Get full text

Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases by Chakraborty, Debdulal, Sinha, Tushar Kanti, Sinha, Sourav, Maiti, Aniruddha, Mukherjee, Angshuman, Nandi, Krishnendu, Das, Sudipta, Majumdar, Saptorshi, Rungta, Dinesh, Bhattacharya, Ranabir

“…This study aims to evaluate the ocular and systemic safety profiles of intravitreal biosimilar ranibizumab Ranieyes (Lupin Pharmaceuticals, Mumbai, India) in…”
Get full text

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence by Chakraborty, Debdulal, Mondal, Soumen, Boral, Subhendu, Das, Arnab, Sinha, Tushar Kanti, Majumdar, Saptorshi, Bhattacharya, Ranabir, Maitra, Ritobroto

“…To analyse outcomes of innovator ranibizumab (IRM) (Lucentis) and biosimilar ranibizumab (BRM) (Razumab) in Indian eyes with neovascular age-related macular…”
Get full text

Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study by Chakraborty, Debdulal, Boral, Subhendu, Sinha, Tushar Kanti, Das, Arnab, Mukherjee, Angshuman, Majumdar, Saptorshi, Bhattacharya, Ranabir, Maitra, Ritobroto

“…This study investigates the efficacy of transitioning patients with neovascular age-related macular degeneration (nAMD) from aflibercept (T1) to biosimilar…”
Get full text